A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Therapsil
English
Next cohort: Jun 1, 2026
10 hours
Start date: June 1, 2026
Aotearoa New Zealand Psilocybin Training is a 106-hour live online course focused on psilocybin-assisted psychotherapy. The curriculum is tailored to the Aotearoa New Zealand context and is delivered in partnership with PsyTrain. The course is structured as a live cohort rather than a self-paced program. It includes expert faculty input and a supervised clinical pathway to support learning for clinical practice. The source does not specify eligibility requirements, accreditation, certificate details, pricing, or scholarship availability.
Clinicians and other healthcare professionals seeking training in psilocybin-assisted psychotherapy for clinical practice.
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Synthesis
An 8-day immersive apprenticeship retreat in the Netherlands focused on ethical psychedelic facilitation and group space-holding. Participants observe, support, and reflect within a clinically informed, somatically intelligent training structure.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.